Literature DB >> 2264399

[Interpretation of postmortem digoxin levels: evaluating a "corrective factor" for postmortem blood digoxin concentration].

S Ritz1, H J Kaatsch.   

Abstract

Interpretation of postmortem serum digoxin levels is made difficult above all by a possible prefinal or postmortem rise in digoxin concentrations in the blood. To compensate for this postmortem increase, Eriksson et al. (1984) divided the level of postmortem digoxin in femoral venous blood by a factor of 1.5; in the opinion of these authors, postmortem digoxin levels still exceeding "therapeutic levels" after division by 1.5 are an index of digoxin overdose. The diagnostic value of this "correction factor" was investigated. In 56 cases with documented digoxin medication, samples of postmortem femoral venous blood were taken and the level of digoxin determined. In none of the cases had there been a clinical diagnosis of digoxin intoxication. Fifty percent of the measured values were above "therapeutic levels" (0.7 ng/ml to 2.2 ng/ml). Following division by 1.5, 20% of the cases still showed levels exceeding 2.2 ng/ml; the highest "corrected" value was 4.44 ng/ml. Taking into account the length of time between final dosage and death, individual differences in sensitivity to digitalis glycoside, and the complexity of ante- and postmortem dispersion processes, we concluded for the cases we studied that an (undetected) digoxin overdose was not even likely in those cases whose postmortem values after division by 1.5 lie above "therapeutic levels". The "correction factor" proposed by Eriksson et al. (1984) is only of limited diagnostic value; at best the "corrected" values can give an approximate indication of the corresponding antemortem serum digoxin concentrations. In particular, "corrected" values only a little above "therapeutic levels" could not confirm suspicion of an overdose with sufficient certainty.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2264399     DOI: 10.1007/bf01261421

Source DB:  PubMed          Journal:  Z Rechtsmed        ISSN: 0044-3433


  11 in total

1.  Correlation of antemortem and postmortem digoxin levels.

Authors:  T E Vorpahl; J I Coe
Journal:  J Forensic Sci       Date:  1978-04       Impact factor: 1.832

2.  Myocardial digoxin concentrations in fatal intoxications.

Authors:  E Iisalo; M Nuutila
Journal:  Lancet       Date:  1973-02-03       Impact factor: 79.321

3.  [Validity of digoxin concentrations in blood determined post mortem (author's transl)].

Authors:  R Aderjan; R Mattern
Journal:  Z Rechtsmed       Date:  1980

4.  [Classification of digoxin concentrations in blood and tissues in cases under suspicion of poisoning].

Authors:  W Härdle; R Aderjan
Journal:  Z Rechtsmed       Date:  1983

5.  [Problems in the determination of digoxin poisonings].

Authors:  R Aderjan
Journal:  Beitr Gerichtl Med       Date:  1980

6.  Investigation of cardiac glycoside levels in human post mortem blood and tissues determined by a special radioimmunoassay procedure.

Authors:  R Aderjan; H Buhr; G Schmidt
Journal:  Arch Toxicol       Date:  1979-06-08       Impact factor: 5.153

7.  Interpretation of excessive serum concentrations of digoxin in children.

Authors:  G Koren; R Parker
Journal:  Am J Cardiol       Date:  1985-04-15       Impact factor: 2.778

8.  Falsely elevated digoxin concentrations in patients with liver disease.

Authors:  B Rosenkranz; J C Frölich
Journal:  Ther Drug Monit       Date:  1985       Impact factor: 3.681

9.  [Digoxin concentrations in plasma and tissue. A postmortal investigation (author's transl)].

Authors:  J Weinmann; J Hasford; J Kuhlmann; P H Bippus; J Lichey; N Rietbrock
Journal:  Med Klin       Date:  1979-04-20

10.  Serum levels of digoxin in sudden cardiac deaths.

Authors:  M Eriksson; O Lindquist; B Edlund
Journal:  Z Rechtsmed       Date:  1984
View more
  1 in total

1.  Measurement of digitalis-glycoside levels in ocular tissues: a way to improve postmortem diagnosis of lethal digitalis-glycoside poisoning? I. Digoxin.

Authors:  S Ritz; P Harding; W Martz; H W Schütz; H J Kaatsch
Journal:  Int J Legal Med       Date:  1992       Impact factor: 2.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.